U.S. markets close in 1 hour 45 minutes
  • S&P 500

    3,843.91
    -9.16 (-0.24%)
     
  • Dow 30

    31,048.23
    -127.78 (-0.41%)
     
  • Nasdaq

    13,518.38
    -12.54 (-0.09%)
     
  • Russell 2000

    2,142.36
    +0.94 (+0.04%)
     
  • Crude Oil

    52.34
    -0.79 (-1.49%)
     
  • Gold

    1,856.40
    -9.50 (-0.51%)
     
  • Silver

    25.55
    -0.31 (-1.20%)
     
  • EUR/USD

    1.2176
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.0890
    -0.0200 (-1.80%)
     
  • GBP/USD

    1.3683
    -0.0047 (-0.34%)
     
  • USD/JPY

    103.8060
    +0.3010 (+0.29%)
     
  • BTC-USD

    33,227.07
    +2,743.33 (+9.00%)
     
  • CMC Crypto 200

    658.98
    +48.99 (+8.03%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

Sinovac's COVID-19 vaccine over 50% effective, reports newspaper Folha

·1 min read

SAO PAULO, Dec 23 (Reuters) - Sinovac Biotech's vaccine against COVID-19 is over 50% effective in late-stage trials, newspaper Folha de S. Paulo reported on Wednesday, adding that the Chinese company had asked the Brazilian institute running tests to wait up to 15 days before publishing their full results.

The Butantan Institute, which is running the trial in Brazil, and the government of Sao Paulo, which oversees the institute, declined to comment, saying there would be more details in a news conference at 4 p.m. local time. (Reporting by Gabriel Araujo and Pedro Fonseca Writing by Gabriel Stargardter Editing by Brad Haynes)